31-Oct-2026 18:46:40
RAINBOWAcquisition and merger
RAINBOW Q2 : CONS NET PROFIT UP 8.3% AT RS 81.89 CR (YOY), UP 30.9% (QOQ)
• Revenue up 22.1% at ₹543.02 Cr (YOY), up 15.5% (QOQ). • EBITDA up 13.4% at ₹178.11 Cr (YOY); margins 32.8% vs 35.3% (YOY), 31.4% (QOQ). • Super Prime Medical Care LLP: 64% partnership interest acquired for ₹19.84 Cr, consolidated from 14 August 2026.
Rainbow Children's Medicare Ltd
Open attachment